Home
overview
In recent years there has been a definitive shift in the use of POCT with a predictive market growth expectancy of 27% in the next five years. SMi recognises the importance of this expanding market and subsequently has organised a forum in which leading experts from the pharmaceutical and diagnostics industry will evaluate the latest developments in this arena. This 2nd annual conference on Market Opportunities and Technology Trends in Point of Care Diagnostics will continue the series of well-received events run specifically for the Diagnostics industry

This conference will explore the rapid growth of POCT in terms of technology advancements and health care economics, with a specific focus on glucose, coagulation, infectious disease, drugs of abuse and critical care testing. In addition, it will critically analyse the growth of the global market, assessing the drivers and shapers, and ascertain the significance for individual companies.

A unique opportunity to learn from leading industry experts including:

  • Professor Christopher Price, Vice President, Global Clinical Research, Diagnostics Division, Bayer Healthcare
  • Dr Greg Shipp, Vice President, Medical Affairs, Abbott Point of Care (I-STAT) Division
  • Giuseppe Minola, Head, Near Patient Testing, Business Area Near Patient Testing, Roche Diagnostics
  • Dr Raimund Sterz, Director, Health Economics & Outcomes Research, Abbott
  • Dr Thomas Mann, Clinical Director, National Implementation Team, Commercial Directorate, Department of Health
  • Svein Lien, Chief Executive Officer, Axis-Shield
  • Professor Sam Machin, Consultant Haematologist, University College London Hospitals
  • Clint Severson, President & Chief Executive, Abaxis

Key issues that will be addressed at the Conference include:

  • CURRENT MARKET TRENDS AND DRIVERS: Analyse the latest trends and emerging technologies in the point of care industry
  • NOVEL POINT OF CARE DIAGNOSTIC TESTS: Consider their effectiveness in the sector
  • HEALTH OUTCOMES: Hear about the advantages of point of care testing within an economic and clinical setting
  • PRICING AND REIMBURSEMENT ISSUES: Understand how point of care diagnostics are funded and the subsequent impact on the industry and Government
  • KEY INDUSTRY PERSONNEL: Meet the leaders in the field, make valuable contacts and learn from their experience and expertise

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Doris-Ann Williams

Doris-Ann Williams, Director General, British In Vitro Diagnostics Association (BIVDA)

9:10 KEYNOTE ADDRESS

Harald Stock

Harald Stock, Head of Global Business Development, Roche Diagnostocs GmbH

  • The global point of care marketplace
  • The shift from laboratory testing to point of care tests
  • The geographical split in the market
  • Emerging new technologies
  • The future of POCT
  • 9:50 REGULATIONS IN POCT

    Andrea Molyneaux

    Andrea Molyneaux, , Medicines and Healthcare Products Regulatory Agency (MHRA)

  • The marketplace
  • Reviewing current European regulations
  • The impact of regulations on the industry
  • Minimising regulatory barriers
  • Future plans and policies
  • 10:30 Morning Coffee

    11:00 RANGE OF POCT

    Dr Greg Shipp

    Dr Greg Shipp, Vice President, Medical Affairs, Abbott Point of Care (I-STAT) Division

  • The wide range of point of care assays – from A to Z
  • Differences in platforms and extent of testing on a single platform
  • Improvement in clinical outcomes with use of POCT
  • Future developments
  • 11:40 DRUGS OF ABUSE

    Dr Christopher Hand

    Dr Christopher Hand, Managing Director, Cozart

  • Oral fluid drug testing
  • Techniques involved
  • Functions in criminal justice, medical and at the roadside
  • Future developments
  • 12:20 Networking Lunch

    13:50 RAPID COAGULATION TESTING

    Professor Sam  Machin

    Professor Sam Machin, Consultant Haematologist, University College London Hospitals

  • The majority of POCT are performed on whole blood
  • Advantages of end-point measurements between clotting and bleeding
  • Growth of home self-testing equipment
  • Development of straightforward and swift response analysers
  • 14:30 PROMPT CARDIAC MARKER TESTS

    Dr Kenneth Buechler

    Dr Kenneth Buechler, Senior Vice President, Research & Development, Biosite

  • Fast diagnosis increases patients’ survival rates
  • Reduces unnecessary hospital admissions
  • Improvement of diagnosis using multiple markers
  • Future developments
  • 15:10 Afternoon Tea

    15:30 RAPID HIV ANTIBODY TESTS

    Douglas Michels

    Douglas Michels, President & Chief Executive Officer, OraSure Technolgies

  • What are the current movements?
  • Analysis of the present market and growth potential
  • Advantages of POCT in this sector
  • Future plans
  • 16:10 IMMUNODIAGNOSTICS

    Svein Lien

    Svein Lien, Chief Executive Officer, Axis-Shield

  • The immunodiagnostic sector
  • Advantages for healthcare individuals
  • Market trends associated with immunodiagnostics
  • AFINION™ a new immunodiagnostic point of care system
  • 16:50 AFTER BLOOD GLUCOSE MONITORING

    Bill Cunningham

    Bill Cunningham, Managing Director, CDx

  • Analysing the sales structure of the current global point of care market
  • Essential requirements to make a major impact on sales
  • Sexually transmitted disease screening- a likely candidate?
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Re-registration & Coffee

    9:00 Chairman's Opening Remarks

    Brian Fishwick

    Brian Fishwick, President, British In Vitro Diagnostic Association (BIVDA)

    9:10 MICROFLUIDIC CHIPS FOR POINT OF CARE DIAGNOSTICS

    Dr Ralf-Peter Peters

    Dr Ralf-Peter Peters, Director, Microfluids Division, STEAG microParts

  • Addressing new opportunities in point of care with bioMEMS
  • Selecting a suitable technology platform
  • Development of novel diagnostic devices based on microfluidic design elements
  • Fabrication of microstructured plastic disposables
  • Examples of MEMS-based lateral flow assays for point of care
  • Partnership strategies for global commercialisation success
  • 9:50 NUCLEIC ACID AND PROTEIN ANALYSIS

    Dr John Clarkson

    Dr John Clarkson, Technical Director, Molecular Sensing

  • Advantages of fast analysis
  • Trends in the market
  • Levels of accuracy and sensitivity
  • Future developments
  • 10:30 Morning Coffee

    11:00 CRITICAL CARE

    Charles Mountain

    Charles Mountain, Vice President, Business Development & Technology, Instrumentation Laboratory

  • Needs in critical care testing
  • Point of care grows in response
  • Key advancements – menu, QA, connectivity
  • Standardised system for all testing locations
  • Future directions – further integration
  • 11:40 TRANSFERENCE OF PATIENT ANALYSIS

    Clint Severson

    Clint Severson, President & Chief Executive Officer, Abaxis

  • The financial advantages of POCT
  • Is the shift towards point of care justified?
  • Overall cost benefit
  • More available time for clinical practitioners
  • Future policies
  • 12:20 Networking Lunch

    13:50 INFORMATICS AND POCT

    Dr Andrew St John

    Dr Andrew St John, Consultant, ARC Consulting

  • The impact of informatics on POCT
  • Connectivity standards
  • Integration of POCT into healthcare systems
  • Delivery of evidence-based POCT
  • 14:30 HEALTH CONSEQUENCES ASSOCIATED WITH POCT

    Professor Christopher Price

    Professor Christopher Price, Vice President, Global Clinical Research, Diagnostics Division, Bayer Healthcare

  • How has this form of testing benefited the patient?
  • Practical evidence to clarify the advantages
  • Adapting clinical practices to incorporate POCT
  • Economic benefits of POCT
  • Future challenges and plans
  • 15:10 Afternoon Tea

    15:40 EUROPEAN PERSPECTIVE ON PRICING AND REIMBURSEMENT

    Dr Raimund Sterz

    Dr Raimund Sterz, Director, Health Economics & Outcomes Research, Abbott

  • Reimbursement structure and organisation
  • Indications of pricing benefits
  • Perception of POCT in Europe
  • Long term gain of POCT
  • Forthcoming planning considerations
  • 16:20 PRICING AND REIMBURSEMENT ISSUES

    Dr Mark Charny

    Dr Mark Charny, Managing Director, Translucency

  • Pricing and reimbursement of POCT
  • Legislative reforms
  • Key trends from an NHS perspective
  • Future plans and policies
  • 17:00 Chairman's Closing Remarks and Close of Conference

    +

    Workshops

    The Present Status and Future Prospects for POCT
    Workshop

    The Present Status and Future Prospects for POCT

    Jurys Great Russell Street Hotel
    22nd February 2005
    London, United Kingdom

    Jurys Great Russell Street Hotel

    16-22 Great Russell Street
    London WC1B 3NN
    United Kingdom

    Jurys Great Russell Street Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.